COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Nilotinib in Cognitively Impaired Parkinson Disease Patients 001

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02281474
Recruitment Status : Completed
First Posted : November 2, 2014
Last Update Posted : December 16, 2015
Information provided by (Responsible Party):
Georgetown University

Results Submitted - Not Posted on
Results information has been submitted to by the sponsor or investigator, but is not yet publicly available (or "posted") on The submitted information may not be available if it is pending Quality Control (QC) Review by the National Library of Medicine (NLM) or if issues identified during QC review are being addressed or corrected by the sponsor or investigator. NLM's limited QC review assesses for apparent errors, deficiencies, or inconsistencies. NLM staff do not verify the scientific validity or relevance of the submitted information.
Recruitment Status : Completed
Actual Primary Completion Date : May 2015
Study Completion Date : No date given
Submission Cycle Results Submitted to Results Returned after Quality Control Review
1 September 20, 2016
November 9, 2016
2 August 24, 2018
February 4, 2019
3 November 18, 2019
December 4, 2019
4 March 24, 2020
April 6, 2020